PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

Research To Practice | Oncology Videos · May 16, 2026 · 51m

Featuring an interview with Dr Wassim Abida, including the following topics:

Comparing the clinical relevance of BRCA1 and BRCA2 mutations in prostate cancer (0:00)

Relevance and interpretation of LOH (loss of heterozygosity) scores (4:37)

Incidence and clinical relevance of PALB2 mutations; role of genetic counseling in the care of patients with prostate cancer (9:33)

Key considerations surrounding toxicities associated with PARP inhibitors (15:25)

Potential role of saruparib; evolving nomenclature in prostate cancer (22:36)

Approach to newly diagnosed metastatic prostate cancer (26:16)…